Literature DB >> 11311469

Diagnostic criteria for multiple sclerosis.

C M Poser1, V V Brinar.   

Abstract

Over a hundred years ago, Charcot set down what he considered to be some of the clinical characteristics of multiple sclerosis (MS). His triad was not specific but it was the first attempt to separate this disease from the many others affecting the nervous system. The history of clinical diagnostic criteria demonstrates the evolution from rather tentative classifications of restricted value to the more elaborate 1983 scheme which incorporates some laboratory procedures under the rubric paraclinical tests, considered to be extensions of the neurological examination, as well as a new category based on the presence of specific abnormalities of the cerebrospinal fluid (CSF). It is curious that until then the term definite MS had been avoided except for autopsy-proven cases, perhaps a wise move, since exact diagnosis may require long term observation. All the proposed schemes have been based on the twin principles of dissemination in both time and space. The diagnosis of MS must remain a clinical one, supported but not supplanted by the increasingly popular magnetic resonance imaging, which is non-specific and is frequently overinterpreted by radiologists lacking appropriate clinical information. Reliance on the MRI as the principal if not exclusive basis for the diagnosis leads to error in as many as one third of cases. This assumes a great deal of importance considering that such non-MS patients may be counted in epidemiological surveys and included in therapeutic trials for disease-modifying drugs, or eventually treated with these very expensive drugs with still controversial long term efficacy. Not surprisingly, attempts to develop reliable criteria for the MRI diagnosis of MS have been unsuccessful in view of the lack of specificity of that procedure. Great care should be taken to exclude the presence of extrinsic cervical spine lesions which might impinge on the cord, leading to the formation of plaques, or mimic the course of MS. An MRI of the cervical spine is recommended in all patients suspected of having MS who have symptoms suggestive of spinal cord involvement. The diagnosis of MS is, and will remain, based on clinical criteria which codify the characteristic dissemination in time and space of MS.

Entities:  

Mesh:

Year:  2001        PMID: 11311469     DOI: 10.1016/s0303-8467(00)00125-6

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  29 in total

1.  Jean-Martin Charcot: the father of neurology.

Authors:  David R Kumar; Florence Aslinia; Steven H Yale; Joseph J Mazza
Journal:  Clin Med Res       Date:  2010-08-25

2.  Visualisation of the medial longitudinal fasciculus using fibre tractography in multiple sclerosis patients with internuclear ophthalmoplegia.

Authors:  J P McNulty; R Lonergan; J Bannigan; R O'Laoide; L A Rainford; N Tubridy
Journal:  Ir J Med Sci       Date:  2016-01-19       Impact factor: 1.568

3.  Substrate specificity of catalytic autoantibodies in neurodegenerative processes.

Authors:  A A Belogurov; I N Kurkova; V K Misikov; S V Suchkov; G B Telegin; A I Alekhine; N G Goncharov; V D Knorre; A G Gabibov; N A Ponomarenko
Journal:  Dokl Biochem Biophys       Date:  2007 Mar-Apr       Impact factor: 0.788

4.  Biomarker Detection in Association Studies: Modeling SNPs Simultaneously via Logistic ANOVA.

Authors:  Yoonsuh Jung; Jianhua Z Huang; Jianhua Hu
Journal:  J Am Stat Assoc       Date:  2014-12-01       Impact factor: 5.033

5.  Asymmetrical hip bone density in multiple sclerosis.

Authors:  Rebecca D Larson; Lesley J White
Journal:  Int J MS Care       Date:  2011

6.  Expiratory muscle strength training in persons with multiple sclerosis having mild to moderate disability: effect on maximal expiratory pressure, pulmonary function, and maximal voluntary cough.

Authors:  Toni Chiara; A Daniel Martin; Paul W Davenport; Donald C Bolser
Journal:  Arch Phys Med Rehabil       Date:  2006-04       Impact factor: 3.966

7.  Multiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple Sclerosis.

Authors:  Sushmita Sinha; Michael P Crawford; Sterling B Ortega; Nitin J Karandikar
Journal:  J Mult Scler (Foster City)       Date:  2015-01

Review 8.  Induced Stem Cells as a Novel Multiple Sclerosis Therapy.

Authors:  Chong Xie; Yan-Qun Liu; Yang-Tai Guan; Guang-Xian Zhang
Journal:  Curr Stem Cell Res Ther       Date:  2016       Impact factor: 3.828

9.  Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

Authors:  R A Farrell; D Antony; G R Wall; D A Clark; L Fisniku; J Swanton; Z Khaleeli; K Schmierer; D H Miller; G Giovannoni
Journal:  Neurology       Date:  2009-05-20       Impact factor: 9.910

10.  Association between protective and deleterious HLA alleles with multiple sclerosis in Central East Sardinia.

Authors:  Roberta Pastorino; Cristina Menni; Monserrata Barca; Luisa Foco; Valeria Saddi; Giovanna Gazzaniga; Raffaela Ferrai; Luca Mascaretti; Frank Dudbridge; Carlo Berzuini; Salvatore Bruno Murgia; Maria Luisa Piras; Anna Ticca; Pier Paolo Bitti; Luisa Bernardinelli
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.